Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Entrada Therapeutics, Inc. | 10%+ Owner | Common Stock | 4.38M | $88.6M | $20.23 | Dec 11, 2024 | Indirect |
iTeos Therapeutics, Inc. | 10%+ Owner | Common Stock | 2.74M | $22.9M | $8.37 | Jan 5, 2022 | Indirect |
TCR2 THERAPEUTICS INC. | 10%+ Owner | Common Stock | 0 | $1.72 | Jun 1, 2023 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRDA | Entrada Therapeutics, Inc. | Dec 10, 2024 | 2 | -$917K | 4 | Dec 12, 2024 | 10%+ Owner |
TCRR | TCR2 THERAPEUTICS INC. | Jun 1, 2023 | 1 | $0 | 4 | Jun 5, 2023 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Jan 4, 2022 | 5 | -$6.25M | 4 | Jan 6, 2022 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Dec 3, 2021 | 9 | -$1.68M | 4 | Dec 7, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Nov 30, 2021 | 7 | -$2.88M | 4 | Dec 2, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Nov 26, 2021 | 4 | -$811K | 4 | Nov 30, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Nov 17, 2021 | 8 | -$2.84M | 4 | Nov 24, 2021 | 10%+ Owner |
TRDA | Entrada Therapeutics, Inc. | Nov 2, 2021 | 5 | $2M | 4 | Nov 4, 2021 | 10%+ Owner |
TRDA | Entrada Therapeutics, Inc. | Oct 28, 2021 | 0 | $0 | 3 | Oct 28, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Oct 15, 2021 | 3 | -$469K | 4 | Oct 18, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Oct 12, 2021 | 3 | -$1.54M | 4 | Oct 14, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Oct 7, 2021 | 3 | -$1.42M | 4 | Oct 12, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Oct 1, 2021 | 2 | -$746K | 4 | Oct 5, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Sep 28, 2021 | 2 | -$581K | 4 | Sep 30, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Sep 23, 2021 | 4 | -$1.48M | 4 | Sep 27, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Sep 21, 2021 | 2 | -$933K | 4 | Sep 23, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Sep 16, 2021 | 4 | -$2.59M | 4 | Sep 20, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Sep 14, 2021 | 4 | -$1.26M | 4 | Sep 16, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Sep 9, 2021 | 4 | -$1.63M | 4 | Sep 13, 2021 | 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Sep 7, 2021 | 4 | -$1.24M | 4 | Sep 8, 2021 | 10%+ Owner |